Posts

Showing posts with the label Diabetic Retinopathy Market Trends

Diabetic Retinopathy Market Size, Global Analysis, Mega Trends and Forecast to 2025

Market Analysis: Changes in lifestyle are fueling the threat of diabetes across the world. It is likely to influence the growth of the diabetic retinopathy market positively in the forthcoming years. Key players are investing in research & development for bringing technologically advanced devices and diagnostics in order to treat the disease effectively. It is presumed to encourage the expansion of the diabetic retinopathy market over the next few years. The global Diabetic Retinopathy Market Size is anticipated to grow at a 11.9% CAGR between 2019-2025 , reveals the new Market Research Future (MRFR) report. Diabetic retinopathy, simply put, is a diabetes complication that affects the eyes. It is of two types- proliferative (advanced stage) and non-proliferative (milder form).   This can be attributed to the growing patient population over the years. Diabetic retinopathy is usually referred to eye diseases in diabetic patients. High blood sugar level causes t...

Americas to Have Lion’s Share in Diabetic Retinopathy Market

Market Analysis: The global Diabetic Retinopathy Market is anticipated to grow at a 11.9% CAGR between 2019-2025 , reveals the new Market Research Future (MRFR) report. Diabetic retinopathy, simply put, is a diabetes complication that affects the eyes. It is of two types- proliferative (advanced stage) and non-proliferative (milder form).  Various factors are propelling the diabetic retinopathy market growth. Such factors, as per the latest Market Research Future report, include the advancement of patient monitoring, growing awareness about diabetic retinopathy treatment, rising disposable income, increased health awareness, changing lifestyle, and rise in diabetes patients worldwide. Additional factors pushing diabetic retinopathy market growth include an increase in the geriatric population and an increasing prevalence of blindness owing to diabetes.  On the flip side, lack of insurance facilities, extended time of approval for drugs, and shortage of skilled ophthal...